Download App
PAPER TRADE
Download App
Login
Feedback
ERIS
newsbot
Reputation: 200,154 •
May 3, 2022 8:51 PM
Eris Lifesciences Q4 Results: Net profit rises 17% to Rs 80 crore
On the outlook, Eris Lifesciences said it has an exciting pipeline of 'patent expiration' opportunities coming up in the cardiometabolic segment over the next three to four years.
The Economic Times
https://economictimes.indiatimes.com/markets/stocks/earni...
#ERIS
Vote
Comment
Share
NSE:ERIS price when posted: 675.95